Roche posts HCC trial results, registers five new studies across cancer, MS, flu, COPDSep 18Weekly roundup, 6 itemsbaloxavir marboxilcevostamab
AbbVie sponsors new ABBV-253 solid tumor trial; collaborates on epcoritamab lymphoma studySep 10Weekly roundup, 2 itemsABBV-253AbbVie
AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 resultsJul 31Quarterly updateAbbVie
SunRISe-1 bladder cancer trial posts Phase 2b results; TiTan myeloma trial registeredJul 31Weekly roundup, 2 itemsdaratumumabJohnson & Johnson
BMS week: two label updates, new luspatercept CKD trial, pulmonary fibrosis study registeredJul 24Weekly roundup, 6 itemsadagrasibBristol Myers Squibb
Karuna/BMS opens Phase 3 KarXT relapse prevention trial in schizophreniaJul 7Weekly roundup, 2 itemsBristol Myers Squibbpomalidomide
Genmab reports positive Phase 3 results for epcoritamab plus lenalidomide in DLBCLJun 29Clinical readoutepcoritamab-byspGenmab A/S